Display search results for ** instead (55 products)
10 Jan 2020  |  Asia Pacific
Expedited Regulatory Reviews, Accompanied by Surging Novel Drug Pipelines and a Realigned Distribution System will Propel the Chinese Pharma Industry
With over-4000 pharmaceutical players, China is the second largest pharmaceutical industry globally. Although highly fragmented, global pharma and biopharmaceutical players such as Novartis, Novo Nordisk, and AstraZeneca, have a significant hold capturing at least 8-10Percentage of the market. The market being highly dependent on its distributor ne...
USD 9,000.00 save 10 %
09 Mar 2015  |  Global
Digitization, Decentralization, and Democratization of Healthcare
In this research deliverable, Frost & Sullivan’s senior analyst team across the healthcare sector provide bold perspectives and predictions for the industry in 2015. The markets covered include pharmaceuticals and biotech, medical devices, medical imaging, and healthcare IT, amongst others. The analysis captures the impact of trends which are exp...
11 Jul 2013  |  North America
Determining Brand Perceptions and Preferences
The primary objective of this research is to assess the behavior of North American radiology directors as well as their preferences regarding radiology departments use of medical imaging equipment and services. Supporting the primary objective, this research will also: determine titles of medical equipment purchasers (executives, directors, and man...
10 May 2013  |  North America
A Study of Customer Perceptions and Purchase Intentions in Hospitals
This is a repackaging of this research deliverable. During the fourth quarter of 2009, Frost & Sullivan conducted a Customer Research project titled Medical Imaging IT Middleware: A Study of Customer Perceptions and Purchase Intentions in the U.S. Hospital Market. The study aimed to provide the vendors developing, selling, and implementing medical ...
28 Mar 2013  |  Latin America
Governmental Programs and Investments Stimulate the Market
This study analyzes the Brazilian medical imaging market from 2011 to 2017, focusing exclusively on computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound. The analyzed total market is expected to growth with a single-digit CAGR for 2012 to 2017. This growth rate is mainly driven by the C-class economic growth that allows increa...
21 Dec 2012  |  North America
Brands Named, Purchasing Trends Identified
This survey of 170 laboratory managers and researchers investigates budgets for these product categories: instruments, equipment, chemicals, life science reagents and kits, glassware, plasticware, and general laboratory supplies over the 2011-2013 period. Budgets for service and repair of instruments and equipment also are presented. Additionally,...
26 Nov 2012  |  North America
Opportunities Within Organizations
The primary objective of this research is to identify trends for quantitative polymerase chain reaction (PCR) techniques, specifically the use of nascent digital PCR (dPCR) technology in comparison with the mature real-time quantitative PCR (qPCR) technology. The research strives to compare differences of current and future use between qPCR and dPC...
02 Nov 2012  |  North America
Volume 2: Patient Perspectives
Drug delivery is an important area of drug development in the pharmaceutical and biotechnology industry. In Oncology, developers are interested in understanding the opportunities and parameters for delivery of drugs in outpatient settings, particularly the home. This is important for biotechnology products used in this area as companies seek to des...
27 Sep 2012  |  North America
Volume 1: Oncologist and Infusion Nurse Perspectives
Drug delivery is an important area of drug development in the pharmaceutical and biotechnology industry. This customer research was completed to understand trends, dynamics, and parameters specific to the delivery of drugs to cancer patients; identify physicians prescribing trends relative to delivery considerations; understand the role of reimburs...
28 Aug 2012  |  North America
Changes on the Horizon with Novel Oral Therapies for Musculoskeletal Indications
This research service covers the therapeutics for rheumatic diseases market in the United States from 2009 to 2017, with 2011 as the base year. The focus of this research is on biologics and other treatments prescribed as add-on therapies for rheumatoid arthritis (RA), psoriatic arthritis (PsA), and ankylosing spondylitis (AS); background standard ...
USD 6,750.00 save 25 %